The National DPP → Timeline
In 1996, the National Institutes of Health initiated a randomized clinical trial that showed that a lifestyle intervention with a focus on diet and exercise reduced the incidence of diabetes in high-risk individuals by 58%. Since that time, additional translational studies, large-scale program implementations, and decisions by public and commercial payers to cover prevention programs have evolved the understanding of and access to the National DPP lifestyle change program. This timeline displays that rich history.
The National Institutes of Health initiates a randomized clinical trial evaluating the effectiveness of a lifestyle intervention compared to a medication intervention on the effect of reducing the incidence of type 2 diabetes.
February 7, 2002
The Diabetes Prevention Program Research Group publishes findings from its randomized clinical trial in the New England Journal of Medicine, and substantiates that a structured lifestyle program reduced the incidence of diabetes in high-risk individuals by 58%.
Ackermann, et al, publish a study in the American Journal of Preventive Medicine that identifies the YMCA as a “promising channel” for disseminating a lower-cost lifestyle intervention that is based on the randomized clinical trial but uses a group (v. individual) coaching model.
CDC begins building the National DPP infrastructure. Moving diabetes prevention from research to implementation in communities was a major undertaking. A concerted focus on building the infrastructure for and delivery of the adapted DPP lifestyle change program had not been done in the U.S. until 2010 when Congress authorized the CDC to establish and lead the National DPP.
Congress authorizes the CDC to establish the National Diabetes Prevention Program (National DPP) — a public-private initiative to offer evidence-based, cost effective interventions in communities across the United States to prevent type 2 diabetes.
Rui Li, et al, publishes an article about the cost-effectiveness of diabetes prevention interventions, entitled “Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review” in Diabetes Care. The article arrives at the following conclusion: “Many interventions intended to prevent/control diabetes are cost saving or very cost-effective and supported by strong evidence. Policy makers should consider giving these interventions a higher priority.”
September 13, 2011
The Centers for Medicare and Medicaid Services (CMS) announces that ten states will receive grants through the Medicaid Incentives for Prevention of Chronic Disease (MIPCD) program. Among those states, New York, Montana, and Minnesota planned to utilize grant funds to administer incentives to beneficiaries who participate in the National Diabetes Prevention Program.
Montana Medicaid starts offering the Montana Diabetes Prevention Program as a covered benefit to Medicaid beneficiaries. It secures this authority through a state plan amendment.
CDC awards 1212 grants to six national organizations to increase the number of CDC-recognized organizations offering lifestyle change programs via multi-state networks and to expand coverage through relationships with employers and insurers that lead to benefit coverage and reimbursement for delivery organizations.
The CDC posts a funding opportunity for State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health. The CDC awarded 1305 grants to all 50 states and D.C. to raise awareness of prediabetes, increase referrals to CDC-recognized programs, and work with State Employee Benefit Plans and Medicaid to support coverage.
CDC awards 1422 grants to 17 states and 4 cities to expand on work started by 1212 and 1305 and enroll vulnerable, high-risk populations in the program.
July 13, 2015
The Community Preventive Services Task Force updates its Task Force Finding and Rationale Statement on Diabetes Prevention and Control, based on a review of 53 studies from January 1991 through February 2015. It concludes that combined diet and physical promotion programs are cost-effective, and recommends such interventions for individuals at increased risk for developing type 2 diabetes based on “strong evidence of effectiveness in reducing new-onset diabetes.”
The National Association of Chronic Disease Directors (NACDD), in collaboration with the CDC and Leavitt Partners, initiates a demonstration project to support states in developing a model to deliver the National Diabetes Prevention Program to their Medicaid beneficiaries. Maryland and Oregon are selected to participate.
January 1, 2016
The Minnesota Department of Human Services starts offering the Diabetes Prevention Program as a covered benefit for Medicaid fee-for-service beneficiaries under existing state plan authority.
RTI International publishes an evaluation of a YMCA of the USA (Y-USA) Health Care Innovation Award implementation of the Diabetes Prevention Program to Medicare beneficiaries in 17 YMCA locations. RTI found that in the first five quarters of the program, medical cost savings amounted to $2,636 per participant. Through the first 11 quarters, those attending at least one core session lost 3.8% of their body weight, and those attending at least four core sessions lost 4.5% of their body weight.
March 14, 2016
The CMS Office of the Actuary (OACT) certifies that an expansion of the YMCA USA Diabetes Prevention Program in traditional Medicare would reduce (or not increase) net-Medicare spending. It reviewed results from the first two years of the Y-USA Health Care Innovation Award implementation, the original DPP randomized clinical trial, and a subset of lifestyle change programs recognized by the CDC.
March 23, 2016
The Department of Health and Human Services (HHS) Press Office issues a statement indicating the Administration’s support for expanding the National Diabetes Prevention Program in Medicare.
July 1, 2016
NACDD launches the Medicaid Coverage for the National DPP Demonstration project. The project funds two states, Maryland and Oregon, to develop and implement a delivery model for the National DPP through managed care organizations and/or accountable care organizations. The demonstration will conclude on June 30, 2018.
July 7, 2016
CMS releases a proposed rule to expand coverage of the National Diabetes Prevention Program to Medicare Part-B beneficiaries.
July 25, 2016
The Institute for Clinical and Economic Review (ICER) publishes a Final Evidence report entitled, “Diabetes Prevention Programs: Effectiveness and Value.” ICER assessed 10 U.S. DPP programs with full or pending recognition from the CDC’s Diabetes Prevention Recognition Program. The report concluded that the CDC-recognized programs provided “an incremental or better” net health benefit, and digital programs with fully automated (not human) coaching provided “comparable or better” net health benefit versus standard care.
November 1, 2016
The California Public Employees’ Retirement System (CalPERS) announces that it would cover CalPERS diabetes prevention programs for members at no cost beginning January 2017.
November 4, 2016
CMS finalizes a rule to expand coverage of the National Diabetes Prevention Program (called the Medicare Diabetes Prevention Program) starting January 1, 2018.
The CDC awards twelve 1705 cooperative agreements for a five-year timeframe to build out the National DPP infrastructure in currently underserved areas. This initiative is an effort to ensure that all adults with prediabetes or at high risk for type 2 diabetes have the opportunity to enroll in a CDC-recognized evidence-based lifestyle change program.
See an Event Missing?
Do you have an event that you would like to add to the timeline? Fill out the information below and we’ll review the information for addition to the timeline above.